Cystoscope Market Size, Share Global Analysis Report, 2022–2028

Industry Insights

[219+ Pages Report] According to Facts and Factors, during the forecast period of 2022 to 2028, the global cystoscope market is estimated to develop at a compound annual growth rate (CAGR) of 5.2%. The global cystoscope market was worth USD 590 million in 2021, and it is anticipated to exceed USD 820.2 million by 2028. The study investigates several elements and their consequences on the growth of the global cystoscope market. 

Market Overview

A cystoscope is a medical device consisting of a thin tube with an image sensor (camera) and a light source at the tip. During cystoscopy, the cystoscope is moved along the urethra into the bladder to observe the inside of the urinary bladder and urethra. The source of light at the tip of the cystoscope highlights the inside of the bladder, and the camera displays images in real-time on the monitor screen. The cystoscope is being used to identify, diagnose, track, and treat the causes of numerous urological conditions like blood loss, urethral obstruction, regular urinary tract infection (UTI), pelvic pain, and other bladder and lining abnormalities. The two primary categories of cystoscopes on the market are rigid and flexible.

COVID-19 Impact

Overall, it appears that the negative effect of the COVID-19 outbreak on the cystoscope market varies according to the intensity of each case. For example, the COVID-19 pandemic had less of an impact on urgent treatments, as evidenced by the prostate cancer treatment device market.

Industry Growth Factors

• The increased prevalence of UTIs is attributed to fueling the market growth

The growing prevalence of urinary tract diseases in the world may be attributed to the global cystoscope market's growth. According to the National Kidney Foundation, there are nearly 12 million doctor visits in the United States for urinary tract infections. Other diseases with similar rising incidences, like prostate cancer, bladder cancer, stones, and so on, will also propel the market growth during the specified time frame. According to Cancer Research UK, prostate carcinoma is the most prevalent cancer in men, with approximately 47,700 new cases diagnosed in the UK each year. 

Infections of the urinary tract are among the most common in the United States. Women over the age of 65 have a prevalence of around 22.2%, compared to around 10% of the general population. Furthermore, there are approximately 260,000 cases of pyelonephritis in the United States each year, with females being more likely to be affected. The total estimated incidence of pyelonephritis in women aged 18–50 years is around 28/10,000. In the coming years, these trends are anticipated to fuel novel cystoscope applications and devices. 

Restraints

• Medical complications may stymie market growth

Complications like bleeding, infections and swollen urethra that can occur during cystoscopy procedures may limit market growth during the forecast period.

Opportunities

• NBI technology is anticipated to create potential opportunities for market growth

During the forecast period, technological developments in the advancement of imaging technology like narrow-band imaging (NBI) for successfully targeting bladder tumor biopsies are anticipated to create potential business development opportunities. Only Olympus Corporation provides the NBI endoscopic with luminous technology for identifying bladder tumor biopsies without using dyes or drugs.

Segmentation Analysis

The global cystoscope market is segregated on the basis of type of product, technology, and region.

By type of product, the market is divided into rigid cystoscope and flexible cystoscope. The rigid cystoscope is a slim and straight telescope that has been used in urology for many years. Although the rigid cystoscope fragment dominated the global market, it is expected to lose market share by the end of 2028. The flexible cystoscope is a flexible, thin, pencil-shaped fiber-optic telescope with a maneuverable tip that can be passed along the urethral curves. A flexible telescope is commonly used to diagnose and monitor bladder tumors. During the forecast period, the market for flexible cystoscopes is expected to expand at a rapid pace.

By technology, the market is classified into video cystoscope and fiber optic cystoscope. Fiber optic technology has traditionally been used in flexible cystoscopes, accounting for a significant share of the market. By the end of 2028, video cystoscopes are expected to gain market share.

Report Scope

Regional Landscape

• North America and Europe dominate the global market

North America and Europe dominated the global cystoscope market and are expected to retain their dominance by the end of 2028. A large portion of these regions' success is due to well-established healthcare infrastructure, early adoption of cutting-edge technology for the treatment & diagnosis of urological disorders, rising occurrences of prostate cancer, and high healthcare spending.

Asia Pacific market is expected to grow at a significant CAGR during the forecast period, owing to constantly advancing care settings in developing markets such as China, India, Korea, and Singapore, increased access to health care, and increased adoption of cystoscopes in ambulatory surgery centers & hospitals. During the forecast period, the market in Latin America and the Middle East & Africa is expected to expand at a moderate pace. The cystoscope market in these regions is expected to grow fractionally by 2028.

Recent Developments

• April 2019: Neoscope 2020 launched a new Neoscope Video Processing Module (VPU 5) with Light Intensity Control for use with commercial HD video monitors, as well as a Neoscope Video Link Module (NVL) for use with commercial tablet and laptop computers. Both the Model NVL and the Model VPU 5 are fully compatible with the Family of Single-Use Digital Endoscope Products, which includes Single-Use Rigid/Flexible Video Cystoscopes, Flexible/Semi-Rigid Ureteroscopes, and the Family of Nephroscopes for the Treatment of Urological Disorders.
• March 2021: Lucintel is delighted to announce UroViu Corporation's Cystoscopy Platform as the winner of the "2021 Product Innovation Award in the Single-Use Endoscopy Market." Lucintel chose UroViu Corporation for this award because of its novel, one-of-a-kind, single-use, disposable, and portable cystoscopy platform, which enables physicians to undertake interventional and predictive urologic methods in any room, at any time, without the need for reprocessing or peripherals.

Competitive Landscape

Some of the main competitors dominating the global cystoscope market are :

• Schoelly
• Coloplast
• Richard Wolf
• NeoScope Inc
• Olympus
• Ackermann
• HOYA (Pentax Medical)
• Cook Medical
• Tiansong Medical Instrument
• Stryker
• Shenda Endoscope
• Karl Storz
• Laborie Medical

The global cystoscope market is segmented as follows:

By Type of Product Segment Analysis

• Rigid Cystoscope
• Flexible Cystoscope

By Technology Segment Analysis

• Video Cystoscope
• Fiber Optic Cystoscope

By Regional Segment Analysis

• North America
  • The U.S.
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Nordic countries
    • Denmark
    • Finland
    • Iceland
    • Sweden
    • Norway
  • Benelux Reunion
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America